Literature DB >> 24726728

Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.

Xiao Ling Li1, Matthew F Jones1, Murugan Subramanian1, Ashish Lal2.   

Abstract

MicroRNAs are potent regulators of gene expression and modulate multiple cellular processes including proliferation, differentiation and apoptosis. A number of microRNAs have been shown to be regulated by p53, the most frequently mutated gene in human cancer. It is has been demonstrated that some mutant p53 proteins not only lose tumor suppressor activity, but also acquire novel oncogenic functions that are independent of wild-type p53. In this review, we highlight recent evidences suggesting that some mutant p53 proteins regulate the expression of specific microRNAs to gain oncogenic functions and identify a gene network regulated by the microRNAs downstream of mutant p53.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; Gain-of-function; Invasion; Let-7; Metastasis; Mutant p53; miR-128-2; miR-130b; miR-155; miR-205; miR-223; miR-27a; miRNA; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24726728      PMCID: PMC6314029          DOI: 10.1016/j.febslet.2014.03.054

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

Review 2.  A step-by-step microRNA guide to cancer development and metastasis.

Authors:  Georgios S Markopoulos; Eugenia Roupakia; Maria Tokamani; Evangelia Chavdoula; Maria Hatziapostolou; Christos Polytarchou; Kenneth B Marcu; Athanasios G Papavassiliou; Raphael Sandaltzopoulos; Evangelos Kolettas
Journal:  Cell Oncol (Dordr)       Date:  2017-07-26       Impact factor: 6.730

3.  KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro.

Authors:  Anyu Luo; Hanlin Liu; Chen Huang
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111

4.  Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.

Authors:  Qiang Ju; Lina Zhao; Jiajia Gao; Lanping Zhou; Yang Xu; Yulin Sun; Xiaohang Zhao
Journal:  Chin J Cancer Res       Date:  2019-06       Impact factor: 5.087

5.  Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.

Authors:  Emmanuela Falcone; Luca Grandoni; Francesca Garibaldi; Isabella Manni; Giancarlo Filligoi; Giulia Piaggio; Aymone Gurtner
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

6.  MiR-27a-3p Regulated the Aggressive Phenotypes of Cervical Cancer by Targeting FBXW7.

Authors:  Wei Ben; Guangmei Zhang; Yangang Huang; Yuhui Sun
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

7.  MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.

Authors:  Sameer A Dhayat; Wolf Arif Mardin; Jochen Seggewiß; Anda Jana Ströse; Christiane Matuszcak; Richard Hummel; Norbert Senninger; Sören Torge Mees; Jörg Haier
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

Review 8.  The expanding regulatory universe of p53 in gastrointestinal cancer.

Authors:  Andrew Fesler; Ning Zhang; Jingfang Ju
Journal:  F1000Res       Date:  2016-04-26

Review 9.  Pleiotropic functions of miR107 in cancer networks.

Authors:  Zhiying Luo; Yi Zheng; Wei Zhang
Journal:  Onco Targets Ther       Date:  2018-07-18       Impact factor: 4.147

10.  Repression of Irs2 by let-7 miRNAs is essential for homeostasis of the telencephalic neuroepithelium.

Authors:  Virginia Fernández; Maria Ángeles Martínez-Martínez; Anna Prieto-Colomina; Adrián Cárdenas; Rafael Soler; Martina Dori; Ugo Tomasello; Yuki Nomura; José P López-Atalaya; Federico Calegari; Víctor Borrell
Journal:  EMBO J       Date:  2020-09-28       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.